Table I.
Characteristic | Patient 1 | Patient 2 |
---|---|---|
Age at diagnosis, years | 57 | 62 |
Primary tumor staging | cT3cN0M0 | cTxcN1M0 |
Histology | Squamous cell carcinoma | Adenocarcinoma |
Primary treatment | Chemoradiotherapy followed by surgery | Chemoradiotherapy (surgery not indicated due to comorbidities) |
Disease-free interval, months | 18 | 21 |
Site of recurrence | Lower neck lymph nodes | Neck lymph nodes |
Number of fractions of SBRT | 5 | 5 |
Dose prescribed, Gy | 30 | 40 |
Prescription isodose, % | 65 | 81 |
Maximum dose, Gy | 45.9 | 49.2 |
Dose gradient (Paddick) | 0.17 | 0.12 |
Conformity index (ICRU 83) | 0.91 | 0.88 |
Maximum dose to trachea, Gy | 32.6 | Not applicable |
Maximum dose to major blood vessels, Gy | 35.4 | 45.7 |
Maximum dose to esophagus, Gy | 27 | Not applicable |
SBRT, stereotactic body radiotherapy; ICRU, International Commission on Radiation Units.